Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer-Reply

Affiliations

Comment

Michael P Chu et al. JAMA Oncol. 2018.

. 2018 Feb 1;4(2):265.

doi: 10.1001/jamaoncol.2017.3410.

No abstract available

Comment on

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.
Chu MP, Hecht JR, Slamon D, Wainberg ZA, Bang YJ, Hoff PM, Sobrero A, Qin S, Afenjar K, Houe V, King K, Koski S, Mulder K, Hiller JP, Scarfe A, Spratlin J, Huang YJ, Khan-Wasti S, Chua N, Sawyer MB. Chu MP, et al. JAMA Oncol. 2017 Jun 1;3(6):767-773. doi: 10.1001/jamaoncol.2016.3358. JAMA Oncol. 2017. PMID: 27737436 Free PMC article. Clinical Trial.
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
Li GF, Yu G, Gong Y. Li GF, et al. JAMA Oncol. 2018 Feb 1;4(2):264. doi: 10.1001/jamaoncol.2017.3407. JAMA Oncol. 2018. PMID: 29098270 No abstract available.
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
Wang L, Shan B, Gu W. Wang L, et al. JAMA Oncol. 2018 Feb 1;4(2):263. doi: 10.1001/jamaoncol.2016.6615. JAMA Oncol. 2018. PMID: 29098276 No abstract available.
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
Hussaarts KGAM, van Leeuwen RWF, Mathijssen RHJ. Hussaarts KGAM, et al. JAMA Oncol. 2018 Feb 1;4(2):263-264. doi: 10.1001/jamaoncol.2016.7019. JAMA Oncol. 2018. PMID: 29098281 No abstract available.